Skip to main content
. 2005 Apr 30;20(2):225–228. doi: 10.3346/jkms.2005.20.2.225

Table 4.

Mycoplasma pneumoniae and Chlamydia pneumoniae seroprevalences in the COPD and control groups

graphic file with name jkms-20-225-i004.jpg

Data are presented as the number of seropositive patients (seroprevalence %) n, number of total patients.